POLA PENGGUNAAN OBAT PADA PASIEN HEPATITIS B RAWAT INAP DI RUMAH SAKIT UMUM SARILA HUSADA SRAGEN TAHUN 2019

Heni, Widihastuti (2020) POLA PENGGUNAAN OBAT PADA PASIEN HEPATITIS B RAWAT INAP DI RUMAH SAKIT UMUM SARILA HUSADA SRAGEN TAHUN 2019. Diploma thesis, Sekolah Tinggi Ilmu Kesehatan Nasional.

	Text Fulltext Heni Widihastuti.pdf Restricted to Repository staff only Download (1MB)
	Text KTI.pdf Download (566kB)

Abstract

Hepatitis B is a liver infection disease caused by the hepatitis B virus where this virus can cause acute and chronic diseases. This study aims to determine the description of drug use in hepatitis B patients hospitalized at Sarila Husada Sragen General Hospital in 2019. This study is a non-experimental study conducted retrospectively and analyzed descriptively. Study population 95 sheets of medical records 75 study samples were taken using non propability sampling techniques. The sample of this study included: hepatitis B patients who had complete medical record data containing at least the age, sex, type of health care guarantee, diagnosis, there were positive HBsAg laboratory results. The results showed the characteristics of patients by age the most were age 56-65 years 31%, the characteristics of patients by sex the most were males 57.33%, the characteristics of patients based on the type of health care insurance the most were BPJS 53, 33%, the characteristics of patients based on the diagnosis of hepatitis B with or without other diseases most are with other diseases 100%, the percentage based on the most widely used drugs are Curcumin 13.56%, ondansentron 13.27%, ranitidine 8.67%, Echinaceae 4.88%, paracetamol and metamizole respectively 4.61%, spironolactone 3.52%, liver aminophyte 1.63%, lamivudine 0.54%.

Actions (login required)

View Item